Cohort Studymoderate evidence
Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition.
The Journal of clinical endocrinology and metabolism·May 19, 2026·PMID 41482729
Why it mattersInsulin may serve as an early, modifiable marker of metabolic dysfunction that influences the timing and severity of vasomotor symptoms, offering a potential target for risk stratification and preventive counseling in midlife women.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled